An open-label, randomized, single dose, two period, crossover study to determine the bioavailability of valsartan oral solution formulation relative to the valsartan tablet formulation [Diovan; Novartis] in healthy adult subjects.

Trial Profile

An open-label, randomized, single dose, two period, crossover study to determine the bioavailability of valsartan oral solution formulation relative to the valsartan tablet formulation [Diovan; Novartis] in healthy adult subjects.

Completed
Phase of Trial: Phase I

Latest Information Update: 03 Sep 2016

At a glance

  • Drugs Valsartan (Primary)
  • Indications Hypertension
  • Focus Pharmacogenomic; Pharmacokinetics
  • Sponsors Novartis
  • Most Recent Events

    • 04 Jan 2011 Status changed from not yet recruiting to completed as reported by Clinical Trials Registry - India record.
    • 13 Sep 2010 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top